Connect with us

The Plunge Daily

SII, Bharat Biotech to ramp up Covid-19 vaccine production amid deadly second wave


SII, Bharat Biotech to ramp up Covid-19 vaccine production amid deadly second wave

Amid a surge in Covid-19 cases, Serum Institute of India, Bharat Biotech have been asked by government to raise capacities of Covid-19 vaccines, Covishield and Covaxin, respectively. A government panel visited the facility recently and asked the manufacturers to come up with innovative ways to ramp up capacities amid unprecedented demand due to the second wave. The manufacturers are also mulling repurposing of existing capacities or manufacturing tie-ups in view of the huge demand, Business Standard reported quoting a government official.

Last week, Hyderabad-based Bharat Biotech had written to the Centre seeking funds worth Rs 100 crore to ramp up the production of its coronavirus vaccine Covaxin while Pune-based Serum Institute of India (SII) has also verbally requested for funds from the Government’s Covid Suraksha scheme to increase its production. The move follows the increased demand of vaccines amid government’s decision to vaccinate all above the age of 45 years.

Currently, Bharat Biotech is producing 4 million doses of Covaxin per month at their Hyderabad-based plant. Similarly, the SII has set a target to increase the output from 60 million doses to 100 million per month, the Economic Times reported.

The country, with the most number of reported COVID-19 cases after the United States and Brazil, has so far injected more than 80 million doses and exported nearly as many. The cumulative number of coronavirus vaccine doses administered crossed 8.31 crore, the health ministry said. Of these, 43,00,966 were given on Monday.

Also Read: 

Localized lockdowns will take a toll on businesses

India on Tuesday recorded 96,982 daily cases, taking the country’s overall tally to 1,26,86,049. The toll went up to 1,65,547 after 446 deaths were registered in 24 hours. The active cases rose for the 27th straight day to 7,88,223. As many as 1,17,32,279 people have recovered from the infection in the country.



  1. David Raj

    April 7, 2021 at 1:18 am

    Vaccine production/capacity planning should have happened months ago. Government had 6 months time last year. While other country governments were busy in placing orders since May 2020, Modi government didn’t place any serious order until March this year. They did nothing to plan the vaccine production last year. They wasted all precious time. They were just making some empty promises, nothing happened on ground. Government was not proactive, very much reactive to the last minute developments. There was no plan, no foresightedness, no vision with government. Now, they are stealing vaccines which are meant for other poor country exports. Vaccine nationalism can be seen at its best, country’s reputation and trust factor got damanged. Mandir, Cricket, Elections are more prioritised and planned than Vaccinations. With such bad government with misplaced priorities at centre, country deserves another economic slowdown, millions of job losses, lockdowns. Feel sorry for poor, as they are the ones who will be hit harder.

  2. Pingback: Covid-19: Health ministry clears the air amid call for 'vaccination for everyone'

  3. Pingback: Govt panel to probe side effects of Covid-19 vaccines after concerns in Europe

  4. Pingback: Johnson & Johnson in talks with India for trial of single-dose vaccine

  5. Pingback: Serum Institute picks up stake in online insurance unicorn PolicyBazaar

  6. Pingback: 'Farmers are priority': Centre asks fertiliser firms not to hike MRP on non-urea products

Leave a Reply

Your email address will not be published. Required fields are marked *

To Top